Robin Carhart-Harris: Psilocybin vs Antidepressants
Named one of Time Magazine’s most influential people of 2021, Robin Carhart-Harris conducts some of the most impactful psychedelic research in the world.
A conversation series with leaders in the psychedelic community specifically for therapists, healers, retreat leaders, and passionate enthusiasts.
Named one of Time Magazine’s most influential people of 2021, Robin Carhart-Harris conducts some of the most impactful psychedelic research in the world.
Whether psychedelic therapists should have their own experiences with these compounds as part of their training is a passionately debated subject.
The world of digital therapeutics is booming just as fast as psychedelic therapy. Today’s guest, Lyle Maxson, is resolutely optimistic about the positive synthesis of the two.
Lisa Dannen, our colleague at Maya, recently experienced her first Ayahuasca retreat in Peru. Today on the show, she shares all the preparation and integration that went into her experience.
Building a psychedelic company is a lot like creating a healing container. It starts with understanding your role. Something Martijn Schirp, founder of Synthesis, a psilocybin retreat center and institute in the Netherlands discovered early on.
A difficult psychedelic experience once meant a hospital visit… or worse. Now, in the spirit of the Zendo Project and other psychedelic peer support organizations, we have a new hotline called the Fireside Project (call or text 62-FIRESIDE).
There are only a few places in the world which offer legal access to high impact psilocybin retreats. MycoMeditations, stewarded by today’s guest Justin Townsend, is leading the way in ethical psychedelic healing in the unique context of Jamaica.
Today on the Psychedelic Therapy Podcast, for the first time, we are discussing a firsthand account of a patient’s experience of psychedelic therapy. Sydney Bergen shares her experience receiving ketamine infusions administered by Noemi Toth.
A hot topic in the world of psychedelic medicine is whether ketamine infusion therapy is as effective as ketamine-assisted therapy. Today’s guests Dr. Steven Mandel and his son Sam Mandel have administered over 13,000 intravenous treatments.